CONSUELO CLARKE: Open Payments
NPI 1053059196 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 17 payments from 5 companies in 2025. Trend: 2023 $440 · 2024 $541 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $277 |
| Averitas Pharma Inc. | 2 | $150 |
| Boston Scientific Corporation | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 2 | $106 |
| Novo Nordisk Inc | 1 | $20 |
Products named: QUTENZA, RINVOQ, WATCHMAN FLX, SKYRIZI, AIRSUPRA, LINZESS, FARXIGA, Wegovy.
Industry payments across TX — which companies pay providers there.
